# Osaka Small and Medium Business investment & Consultation

> Osaka Small and Medium Business investment & Consultation is a VC fund backing Health Care. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Osaka, Japan
- Total investments: 3
- Last investment: Jan 2025
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://www.sbic-wj.co.jp

Osaka Small and Medium Business investment & Consultation is a public institution that supports the enhancement of equity capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |
| Market Research | 1 | 33% |
| Alternative Medicine | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |
| Venture - Series Unknown | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MiCAN Technologies | MiCAN Technologies medical and nursing Care company we will provide the enabling tools to eliminate Malaria and other infectious diseases by the use of pluripotent stem cell. MiCAN Technologies through the provision of “blood cell-like cell products” produced using regenerative medicine technology,They will help you research malaria and otherinfectious and immune system diseases. | $1.6M | Venture - Series Unknown | Jan 24, 2025 |  |
| CellSeed | CellSeed develops regenerative medicine products primarily in Japan and Europe. The company offers regenerative medicines such as epithelial cell sheet for corneal and esophageal regeneration, regenerated cardiac patch to treat heart diseases, cell sheet for periodontal tissue regeneration, and regenerated cartilage sheet for the treatment ofosteoarthritisThe company was founded in 2001 and is headquartered in Tokyo, Japan. | $141.7M | Seed | Sep 30, 2005 |  |
| Setsuro Tech | Seturotech is a biotechnology venture company established on February 22, 2017 by Tatsuya Takemoto (PI: Principal Investigator) of the University of Tokushima as a venture from Tokushima University. In 2015, Takemoto and Masakazu Hashimoto (Osaka University) developed a simple and highly efficient method for producing genetically modified(genome-edited) mice using CRISPR / Cas9, and filed a patent application for the technology. The technology is called fertilized egg electroporation (GEEP method), a technology that introduces molecules required for genome editing by CRISPR into fertilized eggs at high throughput by the power of electricity (electroporation). Using this technology, Seturotech will start from the production and sale of genetically modified mice, and will become a fundamental company providing all genetically modified animals, anticipating the future use of genetically modified animals in industry. | $2.1M | Series A |  |  |

3 of 3 investments shown.

## Co-investors
- [Aozora Bank Ltd.](https://shizune.co/investors/profile/aozora-bank-ltd) — VC Fund, 1 deal together
- [Chushin Venture Capital](https://shizune.co/investors/profile/chushin-venture-capital-6384) — VC Fund, 1 deal together
- Exponential Zaisan Partners — VC Fund, 1 deal together
- [Fast Track Initiative, Inc.](https://shizune.co/investors/profile/fast-track-initiative) — VC Fund, 1 deal together
- [Miraidoa](https://shizune.co/investors/profile/future-venture-capital) — VC Fund, 1 deal together
- HOXIN — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Osaka Small and Medium Business investment & Consultation invest in?

Osaka Small and Medium Business investment & Consultation invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Osaka Small and Medium Business investment & Consultation last invest?

The most recent investment recorded for Osaka Small and Medium Business investment & Consultation closed in Jan 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co